Article Text

PDF
Obstructive sleep apnoea should be deemed a cardiovascular disease
  1. Flávio Danni Fuchs,
  2. Denis Martinez
  1. Division of Cardiology and Graduate Program in Cardiology, Hospital de Clínicas de Porto Alegre, UFRGS, Porto Alegre, Brazil
  1. Correspondence to Professor Flávio Danni Fuchs, Serviço de Cardiologia, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, 2350, Porto Alegre, RS 90035-903, Brazil; ffuchs{at}hcpa.edu.br

Statistics from Altmetric.com

Humans spend between one quarter and one third of their lives sleeping. Any disorder that occurs during this period is likely to impact both on sleep and on the whole 24 h bodily homeostasis. Sleep-related breathing disorders are highly prevalent in patients with cardiovascular disease. Central sleep apnoea (CSA) occurs mostly in patients with heart failure. Obstructive sleep apnoea (OSA) may occur in up to one third of the general population1 and in 71% of patients with resistant hypertension.2 Apnoeas cause intermittent hypoxia, sleep fragmentation and sympathetic hyperactivity.3 Both OSA and CSA may be due to rostral fluid displacement during sleep time.4 OSA involves a sleep-induced reduction of muscle tone, an increase in the CO2 apnoea threshold and a narrowed pharynx predisposing to partial or total upper airway obstruction. Peripharyngeal fat and/or fluid accumulations are causes of airway narrowing.4 Men with body mass index above 30 kg/m2 have a four times higher risk for OSA. OSA prevalence is likely to be increasing worldwide in parallel with the increase in obesity prevalence. A part of the cardiovascular risk of obesity may be mediated …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles